BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4717678)

  • 1. Recent advances in the understanding of anaesthetic-induced malignant hyperpyrexia.
    Bull AB; Harrison GG
    Acta Anaesthesiol Belg; 1973 May; 24(2):97-108. PubMed ID: 4717678
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in the understanding of anaesthetic-induced malignant hyperpyrexia.
    Harrison GG
    Anaesthesist; 1973 Aug; 22(8):373-6. PubMed ID: 4749220
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Procaine for malignant hyperthermia.
    Heffron JJ; Mitchell G
    N Engl J Med; 1975 Jan; 292(5):266-7. PubMed ID: 1110700
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical basis of malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1974 May; 2(5913):241-4. PubMed ID: 4827070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The temperature dependence of halothane-induced contractures of skeletal muscle.
    Suarez-Kurtz G; Sudo RT
    Muscle Nerve; 1986 Jan; 9(1):47-50. PubMed ID: 3951480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A laboratory animal model for malignant hyperpyrexia.
    Durbin CG; Rosenberg H
    J Pharmacol Exp Ther; 1979 Jul; 210(1):70-4. PubMed ID: 36478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant hyperthermia: diagnosis, treatment and investigations of a skeletal muscle lesion.
    Nelson TE; Flewellen EH
    Tex Rep Biol Med; 1979; 38():105-20. PubMed ID: 531756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Studies of the therapeutic value of procaine and lignocaine in malignant hyperpyrexia.
    Clarke IM; Ellis FR
    Br J Anaesth; 1974 Apr; 46(4):315. PubMed ID: 4451610
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical studies on malignant hyperpyrexia.
    Pennington RJ; Worsfold M
    Proc R Soc Med; 1973 Jan; 66(1 Pt 1):69-70. PubMed ID: 4266079
    [No Abstract]   [Full Text] [Related]  

  • 10. [A further case of malignant hyperpyrexia and its treatment with lidocaine, methylprednisolone and verapamil (iproveratril) (author's transl)].
    Csongrady A; Bake I; Pfänder C; Tarmann H; Schneider M; Buttazzoni E
    Anaesthesist; 1976 Feb; 25(2):80-1. PubMed ID: 1267120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology of malignant hyperpyrexia.
    Br Med J; 1973 Feb; 1(5848):249. PubMed ID: 4685313
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of the role of swine skeletal muscle in malignant hyperthermia.
    Campion DR; Topel DG
    J Anim Sci; 1975 Sep; 41(3):779-86. PubMed ID: 125736
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of susceptibility to malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1974 May; 2(5913):245-7. PubMed ID: 4827071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant hyperthermia: halothane- and calcium-induced calcium release in skeletal muscle.
    Fletcher JE; Tripolitis L; Rosenberg H; Beech J
    Biochem Mol Biol Int; 1993 Mar; 29(4):763-72. PubMed ID: 7683948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium uptake into muscle of pigs susceptible to malignant hyperthermia: in vitro and in vivo studies with and without halothane.
    Britt BA; Endrenyi L; Cadman DL
    Br J Anaesth; 1975 Jun; 47(6):650-3. PubMed ID: 238550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical properties of normal and malignant hyperthemia susceptible porcine muscle: effects of halothane and other drugs.
    Gallant EM; Godt RE; Gronert GA
    J Pharmacol Exp Ther; 1980 Apr; 213(1):91-6. PubMed ID: 6965721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium uptake by isolated sarcoplasmic reticulum: examination of halothane inhibition, pH dependence, and Ca2+ dependence of normal and malignant hyperthermic human muscle.
    Blanck TJ; Gruener R; Suffecool SL; Thompson M
    Anesth Analg; 1981 Jul; 60(7):492-8. PubMed ID: 7195664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: New causes of malignant hyperpyrexia.
    Br Med J; 1974 Nov; 4(5943):488. PubMed ID: 4434113
    [No Abstract]   [Full Text] [Related]  

  • 19. [Malignant hyperthermia].
    Reske-Nielsen E; Haase J
    Ugeskr Laeger; 1975 Feb; 137(7):399-400. PubMed ID: 1118942
    [No Abstract]   [Full Text] [Related]  

  • 20. The site of action of caffeine and procaine in skeletal muscle.
    Thorpe WR; Seeman P
    J Pharmacol Exp Ther; 1971 Nov; 179(2):324-30. PubMed ID: 5133603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.